NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

AVI Polymers Extends Winning Streak to 13 Sessions

AVI Polymers, a penny stock, hit its 5% upper circuit limit in Monday's trade, settling at ₹20.95 apiece and extending its winning run to the 13th straight session. The company's Board of Directors will meet on Thursday, May 7, to consider key strategic proposals, including a potential fundraise of approximately ₹500 crore.

The Board will evaluate various capital-raising options such as a Qualified Institutional Placement (QIP), a preferential issue, a private placement, or a combination of other permissible routes, subject to the necessary regulatory and shareholder approvals. The proposed transaction, being assessed at an indicative valuation of around ₹500 crore, is subject to due diligence and execution of definitive agreements.

In addition to the potential fundraise, the Board will consider a proposal to expand the object clause of the company's Memorandum of Association to include information technology, software development, system integration, digital platforms, and allied technology services. This step is intended to support diversification and align the business with emerging technology-driven opportunities.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

QuarterRevenue (₹ crore)Net Profit (₹ crore)
Q4 FY26150.2810.24
Q3 FY26132.327.01
FY26312.1120.33
FY250.060.82

AVI Polymers reported impressive growth in the March quarter, with revenue rising 13.6% quarter-on-quarter from ₹132.32 crore to ₹150.28 crore, while net profit soared 46.1% to ₹10.24 crore from ₹7.01 crore in Q3FY26. For the full year, the company reported revenue of ₹312.11 crore, a significant jump from ₹0.06 crore in FY25, while net profit came in at ₹20.33 crore.

The company exited FY26 in the strongest financial position in its history, with net worth surging to ₹115.99 crore from ₹5.67 crore a year ago, marking a 20.5-fold expansion. Its cash and cash equivalents stood at ₹16.60 crore, while borrowings remained negligible, reflecting a virtually unlevered balance sheet.

AVI Polymers' long-term growth story is anchored in a rapidly expanding digital ecosystem being built through its wholly owned subsidiaries. The company's two platforms, KrishiBuddy and VI Health AI, are expected to serve as the foundation for its technology-led diversification strategy.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

After staging a strong recovery, the shares recovered from the sharp volatility witnessed in early April, when the stock had crashed to ₹10.61 apiece. From the month's low, the stock has rebounded 64% to Monday's close of ₹20.95 apiece. The stock reached a new all-time high of ₹29.41 per share in March, following a 176% surge in February, its biggest monthly gain since November 2025.

Investor Takeaway

Investors should be aware of the potential fundraising plan and its implications on the company's valuation.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.